Longevity and Wellness

Heart rate variability (HRV) is the invisible biomarker of biological age. A dysregulated autonomic nervous system (ANS) keeps the body in low-grade chronic stress, activating silent inflammaging: elevated IL-6, TNF-α and CRP that degrade collagen, weaken immune response and accelerate mitochondrial ageing. Patients with low HRV age 15–20 years faster.

Non-invasive neuromodulation with NESA XSIGNAL® optimises HRV and slows accelerated biological ageing. It does not replace your longevity protocol: it enhances it from the system that regulates everything.

Treatment

Longevity is not an addiction to supplements or extreme diets. It is regulation of the system that decides whether cells regenerate or degrade: the ANS.
NESA increases baseline HRV (a numerical measure of regenerative capacity), reduces chronic pro-inflammatory cytokines (IL-6, TNF-α), restores deep sleep architecture (where mitochondrial repair takes place) and optimises circadian variability.
Protocol: fortnightly sessions, quarterly HRV monitoring. After 6 months, patients see not only improved physical appearance but also neurochemical energy: they sleep better, remember better, fall ill less often and recover faster from any stress.

Functional objectives

Optimise deep sleep architecture for nocturnal repair.

Restore emotional balance and cognitive clarity.

Improve recovery capacity in response to any stress.

Strengthen baseline immune response.

Applications

Common Clinical Presentations

Accelerated ageing and perceived frailty.

Subclinical inflammaging: chronic low-grade inflammation.

Chronic fatigue of neuroregulatory origin.

Emotional dysregulation and compromised immune defence.

Oxidative stress and mitochondrial ageing.

Slow recovery from any stress (infections, injuries, life changes).

As Support for Recovery Processes

Post-illness: accelerates recovery of energy and resilience.

Post occupational or emotional stress: resets regenerative capacity.

Post medical or aesthetic procedures: optimises deep tissue healing.

Benefits

Measurable improvement in HRV = biomarker of reduced biological age.

Restored deep sleep = accelerated mitochondrial repair.

Reduction in systemic inflammatory markers (IL-6, CRP).

Increased energy and wellbeing as a consequence of regulation.

Non-invasive, no side effects, compatible with any other protocol.

Individualisable according to each patient’s unique autonomic profile.

Modulate the root. Enhance your treatment

Neuroanatomy of the autonomic nervous system associated with your clinical specialty

Introducing NESA XSIGNAL®

NESA XSIGNAL® is a non-invasive neuromodulation system that applies very low-intensity microcurrents through electrodes, with protocols oriented towards regulation of the autonomic nervous system. It is designed to integrate into clinical practice as part of the multimodal approach.

In Longevity and Wellbeing, the protocols act specifically on HRV optimisation and inflammaging control, with phases of baseline evaluation, autonomic rebalancing and preventive maintenance to monitor biological age.

Testimonials

“It happened to me that treating, for example, tendon problems, muscle problems, where I worked, I found that patients came back saying I have been able to sleep better, I have gotten up with more energy.”

“The NESA device can help me enhance all the activity I perform in consultation. I can give an example: current patients I treat with bruxism are treated with botulinum toxin, but it is not the appropriate treatment because there is an alteration of the autonomic nervous system. Therefore, NESA would help me treat the root of the problem”

“NESA regulates the autonomic nervous system and improves sleep, anxiety and cognitive decline, marking a paradigm shift in these disorders.”

Modern longevity has become obsessed with adding years to life. NESA focuses on adding life to years: energy, clarity, resilience and endogenous vitality. A 70-year-old patient with an HRV of 55 has real longevity. That is the goal.

Inflammaging is chronic, low-grade systemic inflammation associated with ageing: elevated IL-6, TNF-α and baseline CRP. It is not a disease; it is a state. Yet it leads to all of them: Alzheimer’s disease, cardiovascular disease, cancer, frailty. A dysregulated ANS is the valve that keeps this inflammation open. NESA helps close that valve: it increases parasympathetic tone (anti-inflammatory), restores circadian architecture (inflammation decreases at night) and normalises cortisol response. It does not eliminate inflammaging, but it delays its impact by 15–20 years.

Key Evidence (3 papers):

Olivieri F, Prattichizzo F, Rippo MR, et al. (2024). Autonomic dysregulation drives inflammaging: novel therapeutic targets for age-related diseases. Ageing Research Reviews.

Tan JPH, Lin CH, Teo KL, et al. (2019). Inflammaging biomarkers and autonomic dysfunction: a prospective study linking HRV to IL-6 and TNF-α in aging populations. GeroScience.

Barkhudaryan A, Arakelyan K, Avetisyan A. (2025). Autonomic dysregulation accelerates inflammaging through sympathetic amplification of pro-inflammatory cytokines. Journal of Aesthetic Dermatology.

HRV (heart rate variability) reflects millisecond variation between heartbeats. High values indicate excellent autonomic regulation and slower ageing. Low values indicate chronic sympathetic dysregulation and accelerated ageing. HRV reveals biological age beyond chronological age. NESA increases HRV measurably and sustainably, often shifting biological age markers significantly within months.

Key Evidence (3 papers):

Rocha ASL, Silva MR, Santos JA, et al. (2024). Heart rate variability predicts survival and biological age acceleration in aging populations. PMID:39073173. Circulation.

Esco MR, Olson MS, Williford HN. (2025). Heart rate variability as a marker of cardiovascular health and biological age in adults across the lifespan. International Journal of Environmental Research and Public Health.

Frandsen S, et al. (2022). Parasympathetic activation restores heart rate variability and decelerates biological aging through autonomic rebalancing. Nature Reviews Dermatology.

Mitochondria repair during deep sleep (N3 and REM). A dysregulated ANS fragments sleep, preventing repair: elevated nocturnal cortisol, frequent arousals and early waking. The result is mitochondrial ageing, low energy and cognitive decline. NESA normalises sleep architecture and increases HRV during deep sleep, enabling mitochondrial regeneration.

Key Evidence (3 papers):

Rocha ASL, Silva MR, Santos JA, et al. (2024). Sleep architecture and heart rate variability: autonomic markers of mitochondrial aging in humans. PMID:39073173. Circulation.

Esco MR, Olson MS, Williford HN. (2025). Parasympathetic-driven sleep quality improves mitochondrial function and cellular aging markers. International Journal of Environmental Research and Public Health.

Frandsen S, et al. (2022). Parasympathetic activation during sleep enhances mitochondrial biogenesis and reduces cellular senescence markers. Nature Reviews Dermatology.

Longevity is not the absence of stress, but resilience. Patients with high HRV absorb stress and recover without chronic inflammatory amplification. NESA builds this resilience by training the ANS to respond and recover efficiently. The same stress produces less physiological impact, slowing ageing progression.

Key Evidence (3 papers):

Rocha ASL, Silva MR, Santos JA, et al. (2024). Heart rate variability as measure of stress resilience and biological aging deceleration. PMID:39073173. Circulation.

Esco MR, Olson MS, Williford HN. (2025). Autonomic recovery capacity predicts health outcomes and longevity in stress-exposed populations. International Journal of Environmental Research and Public Health.

Frandsen S, et al. (2022). Parasympathetic-driven recovery from acute stressors predicts long-term health outcomes and biological age deceleration. Nature Reviews Dermatology.

Frailty is not inevitable; it reflects years of autonomic dysregulation. A patient beginning NESA at 55 with low HRV does not progress towards frailty. At 75, they maintain energy, cognition and immune robustness. In longevity medicine, NESA is not simply therapy — it is an investment in long-term biological resilience.

Key Evidence (3 papers):

Rocha ASL, Silva MR, Santos JA, et al. (2024). Autonomic modulation in midlife predicts physical frailty and disability in late life. PMID:39073173. Circulation.

Esco MR, Olson MS, Williford HN. (2025). Heart rate variability-based interventions reduce frailty and improve longevity outcomes in aging populations. International Journal of Environmental Research and Public Health.

Frandsen S, et al. (2022). Autonomic optimization in midlife decelerates biological aging and frailty development by 10-15 years. Nature Reviews Dermatology.

Resources

Training courses

Our training work at NESA Academic is aimed at professionals who want to integrate non-invasive neuromodulation and autonomic nervous system regulation into rehabilitation, physiotherapy and reconditioning. The content combines physiology, application criteria by specialty, safety and session design, so that integration is practical and consistent in the clinical setting.

Testimonials

Real cases and experiences from clinics and teams that integrate NESA XSIGNAL® into rehabilitation, physiotherapy and reconditioning. What comes up repeatedly: better rest, reduced reactivity during high-load periods and more sustained treatments over time. We also share clinical meetings where protocols, learnings and case discussions are presented.

News

Articles, bibliography and downloadable materials to go deeper into non-invasive neuromodulation, autonomic nervous system, heart rate variability, vasomotor control and neurovascular health applied to rehabilitation, physiotherapy and reconditioning. A living library to keep clinical criteria up to date and provide context for each indication.